Shopping Cart
- Remove All
- Your shopping cart is currently empty
Vobarilizumab (ALX-0061) is a humanized, specific monoclonal antibody targeting IL-6R and albumin (ALB), consisting of an anti-IL-6R domain and an anti-human albumin domain, used in the study of rheumatoid arthritis and other autoimmune diseases.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $277 | In Stock | |
5 mg | $888 | In Stock | |
10 mg | $1,490 | In Stock | |
25 mg | $2,230 | In Stock | |
50 mg | $2,960 | In Stock |
Description | Vobarilizumab (ALX-0061) is a humanized, specific monoclonal antibody targeting IL-6R and albumin (ALB), consisting of an anti-IL-6R domain and an anti-human albumin domain, used in the study of rheumatoid arthritis and other autoimmune diseases. |
Targets&IC50 | IL-6R9 (human):2.34 ng/mL (EC50) |
Alias | ALX-0061, ALX0061 |
Cas No. | 1628814-88-9 |
Storage | store at low temperature | store at -20°C | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.